Skip to main content
  1. Right Decisions
  2. Maternity & Gynaecology Guidelines
  3. Maternity
  4. Back
  5. Medical conditions in pregnancy
  6. Central line management, Maternity (1163)
Announcements and latest updates

Right Decision Service newsletter: September 2024

Welcome to the Right Decision Service (RDS) newsletter for September 2024.

1.Business case for permanent provision of the Right Decision Service from April 2025 onwards

This business case has now been endorsed by the HIS Board and will shortly be submitted to Scottish Government.

2. Management of RDS support tickets

To balance increasing demand with available capacity and financial resource, the RDS team and Tactuum are now working together to  implement closer management of support tickets. As a key part of this, we want to ensure clear, timely and consistent communication with yourselves as requesters.  

Editors will now start seeing new messages come through in response to support ticket requests which reflect this tightening up and improvement of our processes.

Key points to note are:

2.1 Issues confirmed by the RDS and Tactuum teams as meeting the critical/urgent and high priority criteria will continue to be prioritised and dealt with immediately.

Critical/urgent issues are defined as:

  1. The Service as a whole is not operational for multiple users. OR
  2. Multiple core functions of the Service are not operational for multiple users.

Example – RDS website outage.

Please remember to email ann.wales3@nhs.scot and his.decisionsupport@nhs.scot with any critical/urgent issues in addition to raising a support ticket.

High priority issues are defined as:

  1. A single core function of the Service is not operational for multiple users. OR:
  2. Multiple non-core functions of the Service are not operational for multiple users.

Example – Build to app not working.

2.2 Support requests that are outwith the warranty period of 12 weeks since the software was originally developed will not be automatically addressed by Tactuum. The RDS team will consider these requests for costed development work and will obtain estimate of effort and cost from Tactuum for priority issues.

2.3 Support tickets for technical issues that are not classified as bugs will not be automatically addressed by Tactuum. The definition of a bug is ‘a defect in the software that is at variance with documented user requirements.’  Issues that are not bugs will also be considered for costed development work.

The majority of issues currently in support tickets fall into category 2 or 3 above, or both.

2.4 Non-urgent requests that require a deployment (i.e a new release of RDS) will normally be factored into the next scheduled release (currently end of Nov 2024 and end of Feb 2025) unless by special agreement with the RDS team.

Please note that we plan to move in the new year to a new system whereby requests all come to an RDS support portal in the first instance and are triaged from there to Tactuum when appropriate.

We will be organising a webinar in a few weeks’ time to take you through the details of the current support processes and criteria.

3. Next scheduled deployment.

The next scheduled RDS deployment will take place at the end of November 2024.  We are reviewing all outstanding support tickets and feature requests along with estimates of effort and cost to determine which items will be included in this deployment.

We will update you on this in the next newsletter and in the planned webinar about support ticket processes.

4. Contingency arrangements for RDS

Many thanks to those of you who attended our recent webinar on the contingency arrangements being put in place to prevent future RDS outages as far as possible and minimise impact if they do occur.  Please contact ann.wales3@nhs.scot if you would like a copy of the slides from this session.

5. Transfer of CKP pathways to RDS

The NES clinical knowledge pathway (CKP) publisher is now retired and the majority of pathways supported by this tool have been transferred to the RDS. Examples include:

NHS Lothian musculoskeletal pathways

NHS Fife rehabilitation musculoskeletal pathways

NHS Tayside paediatric pathways

6. Other new RDS toolkits

Include:

Focus on frailty (from HIS Frailty improvement programme)

NHS GGC Money advice and support

If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot

To go live imminently:

  • Focus on dementia
  • NHS Lothian infectious diseases toolkit
  • Dumfries and Galloway Adult Support and Protection procedures
  • SIGN guideline – Prevention and remission of type 2 diabetes

 

7. Evaluation projects

We have recently analysed the results of a survey of users of the Scottish Palliative Care Guidelines toolkit.  Key findings from 61 respondents include:

  • Most respondents (64%) are frequent users of the toolkit, using it either daily or weekly. A further 25% use it once or twice per month.
  • 5% of respondents use the toolkit to deliver direct patient care and 82% use it for learning
  • Impact on practice and decision-making was rated as very high, with 80% of respondents rating these at a 4-5 on a 5 point scale.
  • Impact on time saving was also high, with 74% of respondents rating it from 3-5.
  • 74% also reported that the toolkit improved their knowledge and skills, rating these at 4-5 on the Likert scale

Key strengths identified included:

  • The information is useful, succinct, and easy to understand (31%).
  • Coverage is comprehensive (15%)
  • All information is readily accessible in one place and users value the offline access via mobile app (15%)
  • Information is reliable, evidence-based and up to date (13%)

Users highlighted key areas for improvement in terms of navigation and search functionality. The survey was very valuable in enabling us to uncover the specific issues affecting the user experience. Many of these can be addressed through content management approaches. The issues identified with search results echo other user feedback, and we are costing improvements with a view to implementation in the next RDS deployment.

8.RDS High risk prescribing (polypharmacy) decision support embedded in Vision and EMIS primary care E H R systems

This decision support software, sponsored by Scottish Government Effective Prescribing and Therapeutics Division,  is now available for all primary care clinicians across NHS Tayside. Board-wide implementation is also planned for NHS Lothian, and NHS GGC, NHS Ayrshire and Arran and NHS Dumfries and Galloway have initial pilots in progress. The University of Dundee has been commissioned to evaluate impact of this decision support software on prescribing practice.

9. Video tutorials for RDS editors

Ten bite-size (5 mins or less) video tutorials for RDS editors are now available in the “Resources for providers of RDS tools” section of the RDS.  These cover core functionality including Save and preview, content page and media management, password management and much more.

10. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Wednesday 23rd October 4-5 pm
  • Tuesday 29th October 11 am -12 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

 

Central line management, Maternity (1163)

Objectives

This guideline and policy aims to provide support to midwifery staff on the management of central venous catheters (referred to subsequently as a “central line” for simplicity) inserted in patients located in maternity areas of the hospital. This guideline provides some background information, guidance on management of central lines, a policy on the circumstances when a central line should be removed, and guidance around how to involve the obstetric anaesthetic team. It references existing health board and national policies on Vascular Access Devices (VAD’s) and Infection control guidelines.

Scope

This guideline and policy is designed for midwifery staff members working in the relevant clinical areas (antenatal ward, labour ward, theatre, theatre recovery, obstetric HDU, postnatal ward) who may be required to care for a patient with a central line in place. During the course of the patient’s clinical journey it is likely there will come a point when the central line can be removed due to an improvement in their clinical condition.

Reasons why a patient in a maternity clinical area may have a central line in place

You may encounter patients with a central line inserted for one of the following reasons:

  • when a patient is known to have difficult intravenous access
  • to administer medication that can only be given via a central vein
  • to provide parenteral nutrition
  • for monitoring of central venous pressure
  • where multiple intravenous medications may need to be given simultaneously
  • where a longer term course of intravenous medication is anticipated
  • for specialised treatments such as Haemodialysis

For many of these reasons it is likely the patient would require to be outside of the obstetric clinical area in ICU, where the line care will be provided by the ICU nurses. Or they may be in Obstetric HDU with midwifery care, with input from the obstetric anaesthetic team. However a patient may be on a standard antenatal, labour, or postnatal ward with a central line. This is usually because the patient’s condition has improved, and some of the HDU or ICU treatments are no longer needed, or because the line was placed specifically for difficult venous access.

A central line is usually inserted by one of the anaesthetic doctors, but may be done by some other specialists if they have the appropriate training. This may be during the patient’s obstetric care journey, or the patient may present in need of obstetric care with a line already in place. It is the responsibility of whoever inserts the line to confirm it is suitable for use. The central line will have a number of ports that should be covered with a Needle Free Access Device (NFAD), that allows medications to be administered, samples to be taken, and keeps the line ports covered when they are not in use.

Common sites where a central line may be visible

  • Neck (for a line placed in an internal jugular vein)
  • Top of Chest (for a line placed in a subclavian vein)
  • Groin (for a line placed in a femoral vein)
  • Arm (usually for tunnelled central lines)

Tunnelled Central Lines and PICC’s

Tunnelled central lines have an insertion site some way away from the vein, and the line is then “tunnelled” underneath the skin towards the vein. A PICC is inserted into a peripheral vein, and is a long line with an end point nearer the central veins. These types of lines are usually inserted when a central line is required for an extended period of time (over 4 weeks), and they are inserted in this way to significantly reduce the risk of a line infection. These lines are outside the scope of this guidance, but it is important to be aware they may be there.

Roles / responsibilities

Midwifery Staff Responsibilities

  • To be able to recognise when a patient has a central line inserted
  • To provide ongoing line maintenance and safe management of the central line
  • To be able to administer intravenous medications via a central line
  • To consult the obstetric anaesthetic team if any advice or support is required
  • To consult the obstetric anaesthetic team prior to removal of a central venous catheter

Obstetric Anaesthetic Responsibilities

  • To document appropriately that a central line is suitable and safe for administering IV medications or blood samples once the necessary checks are completed post insertion
  • To provide advice on line maintenance and usage to the midwifery team
  • To advise the midwifery team when a central line can be safely removed
  • To advise the midwifery team if any additional support is required with central line management

POLICY on Removal of Central Lines

When removing a central line there is a balance to be struck between the need for ongoing IV access and blood sampling in a situation of difficult access against the increased risk of infection the longer a line is in place. Removal too early may necessitate a new central line which carries a repeat set of risks to the patient from reinsertion. Therefore removal of a patient central line by a midwife must be discussed with a Consultant Obstetric Anaesthetist before it happens.

GUIDELINE on Central Line Management

Central Line Maintenance and Care

Inadequate central line care can result in an increased infection risk, increased risk of the line becoming dislodged (which can lead to major haemorrhage or air embolism), and blockage of the lumens (rendering the line non-functional). Line care follows a standard Aseptic Non Touch Technique ®. Early troubleshooting can help to minimise problems. Key points of line maintenance are as follows:

  • Patients should be made aware that they have a central line inserted, to minimise the risk of accidental dislodgement or removal of dressings.
  • The central line site should be inspected at a minimum of once per day, to ensure the line remains in place, the sutures are intact, the dressing remains intact, and there are no signs of infection or bleeding at the insertion site. The dressing is typically a clear tegaderm dressing which does not need to be removed (unless it is damaged or soiled) to inspect the site.
  • If the sutures are no longer in place, this should be highlighted to the obstetric anaesthetic team for review and re-suturing. The sutures should be under sufficient tension to hold the line securely.
  • A clear tegaderm dressing should be placed over the central line. This should be changed at least once per week, or sooner if the dressing has become loose or soiled.
  • All ports should be covered by a Needle Free Access Device (NFAD).
  • Lumens usually have a clamp which should be in a closed position when it is not in use.

 

Obtaining Blood Samples from a Central Line

In a patient with difficult venous access, it is likely to be much easier to obtain blood from a central line that is in place, as opposed to trying in a peripheral vein. Key points are as follows:

  • A standard ANTT® approach with appropriate PPE must be considered
  • The Needle Free Access Device (NFAD) covering the lumen should be cleaned with a 2% Chlorhexidine / 70% Alcohol wipe (“Scrub the Hub”) and allowed to dry for at least 30 seconds
  • The clamp over the line should be released and a 10ml syringe inserted into the end
  • Using this syringe approximately 3-5ml of blood should be aspirated and discarded
    • If a small amount of blood is not discarded this can result in inaccurate results. The volume of blood discarded should be at least 2x the volume contained within the line deadspace, so approximately 3-5ml will be sufficient.
  • A Vacuette tube is then placed on the NFAD using a “push and twist” technique
  • Blood bottles can then be filled as required by inserting them into the Vacuette tube, which can then be released and disposed of in the sharps bin when complete.
  • A fresh 10ml syringe filled with 0.9% saline should be used to flush the lumen through the NFAD using a “push/pause” technique and positive pressure, with the plunger being pushed as the clamp is reapplied.
  • Once this is complete, the NFAD covering the lumen should be cleaned with a 2% Chlorhexidine / 70% Alcohol wipe (“Scrub the Hub”) and allowed to dry for at least 30 seconds.

There are a few additional points to consider regarding taking blood samples from a central line:

  • Taking blood cultures from a central line should ideally be avoided if possible due to the risk of bacterial colonisation resulting in a false positive blood culture result. However if there is a suspicion the line is infected, this may be specifically asked for.
  • It may be difficult or impossible to aspirate blood if the lumen is blocked. Another lumen may be used if this is the case, but if it is not possible to aspirate blood then this should be escalated to the medical team for troubleshooting.
  • If one of the central line ports is being used for TPN, this port should not be used for blood sampling or medication administration due to an increased infection risk.

 

Safe Removal of a Central Line

It is important to remove a central line in a safe manner due to the risk of air embolism or haemorrhage if done improperly. As with blood sampling or IV medicines administration, this should be done with a standard ANTT® approach with appropriate PPE. The following should be considered:

  • An explanation should be given to the patient of what is about to happen.
  • The patient must be lying flat with a head down tilt (Trendenburg position)
  • The dressing should be carefully removed and discarded
  • The area should be cleaned using a 2% chlorhexidine / 70% isopropyl alcohol wand and be allowed to dry for at least 30 seconds
  • The sutures should be released using a stitch cutter and removed
  • The patient should then be asked to hold their breath and perform a Valsalva manoeuvre, as this happens the central line should be withdrawn whilst gentle pressure is immediately applied over the insertion site with a sterile swab
  • The pressure should be maintained until the bleeding has stopped. This may take approximately 5-10 minutes, and should be at least 15 minutes for a femoral line, but could take longer.
  • The site should then be covered with a hydrocolloid dressing. This should stay in place for at least 2 hours.
  • Before discarding the central line it should be inspected for any signs of damage
  • Patients should be advised to minimise any physical exertion for at least 1 hour after removal. If they have had a femoral line in, they should be nursed lying flat for at least 2 hours.
  • The patients observations should be recorded after line removal, and the limb closest to the insertion site should be observed for any changes in skin colour or signs of swelling.